89 related articles for article (PubMed ID: 32468861)
1. Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Nakajima Y; Kuribayashi K; Ishigaki H; Tada A; Negi Y; Minami T; Takahashi R; Doi H; Kitajima K; Yokoi T; Kijima T
Cancer Invest; 2020 Jul; 38(6):356-364. PubMed ID: 32468861
[TBL] [Abstract][Full Text] [Related]
2. Features which discriminate between tuberculosis and haematologic malignancy as the cause of pleural effusions with high adenosine deaminase.
Choe J; Shin SH; Jeon K; Huh HJ; Park HD; Jeong BH
Respir Res; 2024 Jan; 25(1):17. PubMed ID: 38178065
[TBL] [Abstract][Full Text] [Related]
3. Pleural tuberculosis mimicking malignant pleural mesothelioma by
Ai L; Wang W; Li Y
Med Clin (Barc); 2023 Nov; 161(9):415. PubMed ID: 37263842
[No Abstract] [Full Text] [Related]
4. Utility of the cytological criteria in the diagnosis of malignant pleural mesothelioma: Making the bridge between theory and practice.
Mlika M; Yaiche R; Ayadi R; Braham E; Abdennadher M; Mezni F
Tunis Med; 2023 May; 101(5):497-501. PubMed ID: 38372516
[TBL] [Abstract][Full Text] [Related]
5. Detailed clinical course of a patient with rapidly progressing sarcomatoid pleural mesothelioma without p16 deletion with systemic haematogenous metastasis to soft tissues.
Mizuhashi K; Okamoto K; Nabeshima K; Kishimoto T
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38341199
[TBL] [Abstract][Full Text] [Related]
6. Blood cell DNA methylation biomarkers in preclinical malignant pleural mesothelioma: The EPIC prospective cohort.
Allione A; Viberti C; Cotellessa I; Catalano C; Casalone E; Cugliari G; Russo A; Guarrera S; Mirabelli D; Sacerdote C; Gentile M; Eichelmann F; Schulze MB; Harlid S; Eriksen AK; Tjønneland A; Andersson M; Dollé MET; Van Puyvelde H; Weiderpass E; Rodriguez-Barranco M; Agudo A; Heath AK; Chirlaque MD; Truong T; Dragic D; Severi G; Sieri S; Sandanger TM; Ardanaz E; Vineis P; Matullo G
Int J Cancer; 2023 Feb; 152(4):725-737. PubMed ID: 36305648
[TBL] [Abstract][Full Text] [Related]
7. Baseline predictors of negative and incomplete pleural cytology in patients with suspected pleural malignancy - Data supporting 'Direct to LAT' in selected groups.
Tsim S; Paterson S; Cartwright D; Fong CJ; Alexander L; Kelly C; Holme J; Evison M; Blyth KG
Lung Cancer; 2019 Jul; 133():123-129. PubMed ID: 31200818
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Popat S; Baas P; Faivre-Finn C; Girard N; Nicholson AG; Nowak AK; Opitz I; Scherpereel A; Reck M;
Ann Oncol; 2022 Feb; 33(2):129-142. PubMed ID: 34861373
[No Abstract] [Full Text] [Related]
9. Establishing mesothelioma patient-derived organoid models from malignant pleural effusions.
Hocking AJ; Mortimer LA; Farrall AL; Russell PA; Klebe S
Lung Cancer; 2024 May; 191():107542. PubMed ID: 38555809
[TBL] [Abstract][Full Text] [Related]
10. Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Baas P; Fennell D; Kerr KM; Van Schil PE; Haas RL; Peters S;
Ann Oncol; 2015 Sep; 26 Suppl 5():v31-9. PubMed ID: 26223247
[No Abstract] [Full Text] [Related]
11. Psychosocial well-being among patients with malignant pleural mesothelioma.
Demirjian CC; Saracino RM; Napolitano S; Schofield E; Walsh LE; Key RG; Holland J
Palliat Support Care; 2024 Feb; 22(1):57-61. PubMed ID: 36655492
[TBL] [Abstract][Full Text] [Related]
12. Differential diagnosis of pleural mesothelioma using Logic Learning Machine.
Parodi S; Filiberti R; Marroni P; Libener R; Ivaldi GP; Mussap M; Ferrari E; Manneschi C; Montani E; Muselli M
BMC Bioinformatics; 2015; 16 Suppl 9(Suppl 9):S3. PubMed ID: 26051106
[TBL] [Abstract][Full Text] [Related]
13. Detection of malignant mesothelioma using nuclear structure of mesothelial cells in effusion cytology specimens.
Tosun AB; Yergiyev O; Kolouri S; Silverman JF; Rohde GK
Cytometry A; 2015 Apr; 87(4):326-33. PubMed ID: 25598227
[TBL] [Abstract][Full Text] [Related]
14. Differences in Pleural Fluid Amylase Levels in Patients with Malignant Pleural Effusion Based on Cancer Type, Histologic Type, and Epidermal Growth Factor Receptor Mutations.
Shimoda M; Tanaka Y; Morimoto K; Yoshimori K; Ohta K
Intern Med; 2023 Dec; 62(24):3601-3607. PubMed ID: 37081679
[TBL] [Abstract][Full Text] [Related]
15. Intrapleural injection of brucea javanica oil emulsion provided a long-term benefits in patient with malignant pleural effusion from pleural mesothelioma: A case report.
Zhou H; Wang Q; Jiao L; Bi L; Sang S; Han Y; Gan S; Liu R; A G; Gong Y
Explore (NY); 2024; 20(1):126-129. PubMed ID: 37286465
[TBL] [Abstract][Full Text] [Related]
16. Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity.
Mangiante L; Alcala N; Sexton-Oates A; Di Genova A; Gonzalez-Perez A; Khandekar A; Bergstrom EN; Kim J; Liu X; Blazquez-Encinas R; Giacobi C; Le Stang N; Boyault S; Cuenin C; Tabone-Eglinger S; Damiola F; Voegele C; Ardin M; Michallet MC; Soudade L; Delhomme TM; Poret A; Brevet M; Copin MC; Giusiano-Courcambeck S; Damotte D; Girard C; Hofman V; Hofman P; Mouroux J; Cohen C; Lacomme S; Mazieres J; de Montpreville VT; Perrin C; Planchard G; Rousseau N; Rouquette I; Sagan C; Scherpereel A; Thivolet F; Vignaud JM; Jean D; Ilg AGS; Olaso R; Meyer V; Boland-Auge A; Deleuze JF; Altmuller J; Nuernberg P; Ibáñez-Costa A; Castaño JP; Lantuejoul S; Ghantous A; Maussion C; Courtiol P; Hernandez-Vargas H; Caux C; Girard N; Lopez-Bigas N; Alexandrov LB; Galateau-Salle F; Foll M; Fernandez-Cuesta L
Nat Genet; 2023 Apr; 55(4):607-618. PubMed ID: 36928603
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive clinical overview of malignant pleural mesothelioma.
Khan AMH; Anwer SH; Sayed S; Mansha MA; Kamran YB; Khursheed A; Haroon F; Soomro NH; Idrees R; Abbasi AN
Respir Med; 2024 Feb; 222():107511. PubMed ID: 38163522
[No Abstract] [Full Text] [Related]
18. Challenges in lung and thoracic pathology: molecular advances in the classification of pleural mesotheliomas.
Fernandez-Cuesta L; Mangiante L; Alcala N; Foll M
Virchows Arch; 2021 Jan; 478(1):73-80. PubMed ID: 33411030
[TBL] [Abstract][Full Text] [Related]
19. Clinical Value of Pleural Effusion and Serum MMP-3 and CYFRA21-1 Combined with ADA in Differential Diagnosis of Pleural Exudative Effusion.
Xu Z; Guan J; Xu J; Tu J; Cheng J
Emerg Med Int; 2022; 2022():1615058. PubMed ID: 36072615
[TBL] [Abstract][Full Text] [Related]
20. ADA as main biochemical marker in patients with tuberculous effusion.
Janković J; Ilić B; Đurđević N; Jandrić A
J Med Biochem; 2023 Oct; 42(4):722-726. PubMed ID: 38084235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
